Releases Geral
KFSH&RC Welcomes Dr. Björn Zoéga as New Deputy CEO
AGÊNCIA DE COMUNICAÇÃO Conteúdo de responsabilidade da empresa 2 de abril de 2024
King Faisal Specialist Hospital & Research Centre
RIYADH, Saudi Arabia, April 02, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSH&RC) is proud to announce the appointment of Dr. Björn Zoéga as Deputy Chief Executive Officer (CEO), effective 01 April 2024. This strategic move is set to accelerate KFSH&RC’s aspiration of becoming a leading healthcare institution on the global stage, leveraging Dr. Zoéga’s notable career and proven track record of leadership in top-tier medical institutions.
As the former CEO of the internationally renowned Karolinska University Hospital in Sweden, Dr. Zoéga played a pivotal role in upholding the institutions high standards and global recognition as the second highest rated among European hospitals and seventh best worldwide according to Newsweeks ranking of the Worlds Best Hospitals 2024. His administration at Karolinska was marked by innovative strategies and excellence in healthcare deliveryall which he is posed to enrich within KFSH&RC.
Dr. Zoégabrings decades of healthcare management and clinical expertise to KFSH&RC, having spearheaded operations as CEO of the National University Hospital of Iceland and the Stockholm Spine Center. His experience and faculties in research and education are also invaluable, given his former roles as President and Board Chairman of the EU-Cervical Spine Research Society and Chairman of the Scientific Advisory Board of Alvotech.
As Deputy CEO, Dr. Zoéga will serve as chief lead of KFSH&RCs healthcare delivery and research and innovation groups, following on the hospitals commitment to integrating global best practices in healthcare and pursuing cutting-edge medical research and technology.
KFSH&RC extends its invitation to the community, partners, and stakeholders to welcome Dr. Björn Zoéga, as the institution embarks on a promising new chapter in healthcare, committed to fostering a brighter and healthier future for all.
For more information, please contact:
Mr. Essam Al-Zahrani, Media Affairs Acting Head, 0555254429
Mr. Abdullah Al-Awn, Senior Media Editor, 0556294232
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6a2fb3b5-9219-4e72-82fd-8f093f22996e
KFSH&RC Welcomes Dr. Björn Zoéga as New Deputy CEO
King Faisal Specialist Hospital and Research Centre (KFSH&RC) is proud to announce the appointment of Dr. Björn Zoéga as Deputy Chief Executive Officer (CEO), effective 01 April 2024. This strategic move is set to accelerate KFSH&RC’s aspiration of becoming a leading healthcare institution on the global stage, leveraging Dr. Zoéga’s notable career and proven track record of leadership in top-tier medical institutions.
A OESP nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da OESP e sao de inteira responsabilidade da GlobeNewswire
Leia também
-
Releases Geral Análise do IEG reflete tendência na automação de processos
13 de dezembro de 2023DINO DIVULGADOR DE NOTÍCIAS (DINO – 13 dez, 2023) – Em média, 1 em cada 4 CSCs (Centro de Serviços Compartilhados) do Brasil já utilizam alguma tecnologia para captura de contas de
Saiba Mais -
Releases Geral Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering
22 de abril de 2024Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® approved as one of first ustekinumab biosimilars in EuropeEC approval based on
Saiba Mais -
Releases Geral Estudo aponta dados sobre a produção industrial nacional
7 de junho de 2024Brasil--(DINO - 05 jun, 2024) - Segundo os dados apresentados pelo Instituto Brasileiro de Geografia e Estatística (IBGE), a produção industrial nacional cres
Saiba Mais